With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.

Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and more than $650 million in milestones.

CORBIN, Ky. (LEX 18) — Eight-year-old Eli Hill is a name that resonates deeply within the Corbin community. Though Eli tragically passed away over two years ago, his infectious smile and vibrant ...

Eli Lilly (LLY -0.40%) is one of the undisputed leaders in developing anti-obesity medicines, with Novo Nordisk (NVO 1.20%) being its biggest challenger.

Today 55 Years Ago: Legendary #Israeli spy, Eli Cohen, was publicly hanged in Damascus, #Syria. He sacrificed his life to keep Israel safe. Thank you Eli. Rest in Peace. #Israel pic.twitter.com ...

Eli Roth ‘s recently-launched company The Horror Section has signed a deal with Construction Film, the German-based production banner founded by producer and actress Veronica Ferres (“The ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while AstraZeneca leads on invention.

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

Eli Bohannan, a Walmart asset protection investigator, is running for Topeka City Council District 1. Bohannan's campaign priorities include addressing homelessness, infrastructure and education.

Eli Lilly CEO says Trump tariff threat has already achieved the goal of repatriating manufacturing in pharma.

Eli Lilly (LLY) reported first quarter earnings on Thursday, beating Wall Street's expectations on the top and bottom lines, but its stock sank more than 11% in trading despite the win.

Eli Manning is already enshrined in Giants history for his legendary playing career, and now he has his sights set on owning a part of the franchise.